Sichuan Guangsong Pharmaceutical Co., Ltd

Sichuan Guangsong Pharmaceutical Co., Ltd., a joint venture which was established in 1993 and has three shareholders. The first shareholder is Chengdu Licheng Investment Co., Ltd, which has two branches: Chengdu Kanghui Bio-tech Co., Ltd and Chengdu Kindarco Bio-tech Co., Ltd. The second shareholder is Sichuan Medicines & Health Products Import & Export Co., Ltd. The third shareholder is Matsuura Yakugyo Co., Ltd. (Japan). 

As a pioneer in natural plant active pharmaceutical ingredients (APIs) production in China, since its establishment, Guangsong pharmaceutical has been devoted to developing and producing high-quality purified plant extracts. The main products are natural rutin, quercetin, rhamnose, etc, which are widely used in the pharmaceutical, food and cosmetics industries.    

Sichuan Guangsong Pharmaceutical Co., Ltd is located at the southwest airport economic development zone, Shuangliu district of Chengdu city. Our company, as one of plant extraction companies, has a complete quality management system, for the products of our company, we have strict and effective quality control from raw material purchasing, production, inspection to the whole process of sales, to ensure the stability of high-quality products. Since the establishment of the company, we have been successively issued SFDA GMP, FSSC22000 (SGS), KOSHER, HALAL certificates. And we have passed the quality audits of many pharmaceutical corporations in Europe and Japan. We own experienced pharmacy experts and technologists and have developed good cooperation with several European, American and Japanese companies on technology, in addition, we are very pleased to continually acquire fruits in plant active ingredient research and new products' development like sophora japonica powder.

Sichuan Guangsong Pharmaceutical Co., Ltd will, as always, regard the quality policy of “quality creates values, hygiene guarantees health, service returns customer, satisfaction promotes development” as purpose, and take delight in cooperation and development together with our partners all over the world. We are going forward to more contributions to human health.